BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29893509)

  • 41. Platelet bioreactor: accelerated evolution of design and manufacture.
    Thon JN; Dykstra BJ; Beaulieu LM
    Platelets; 2017 Jul; 28(5):472-477. PubMed ID: 28112988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.
    Li CY; Wu XY; Tong JB; Yang XX; Zhao JL; Zheng QF; Zhao GB; Ma ZJ
    Stem Cell Res Ther; 2015 Apr; 6(1):55. PubMed ID: 25884704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives.
    Huang CJ; Sun YC; Christopher K; Pai AS; Lu CJ; Hu FR; Lin SY; Chen WL
    PLoS One; 2017; 12(2):e0171008. PubMed ID: 28152010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The end is just the beginning: megakaryocyte apoptosis and platelet release.
    Li J; Kuter DJ
    Int J Hematol; 2001 Dec; 74(4):365-74. PubMed ID: 11794690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet-rich plasma stimulated by pulse electric fields: Platelet activation, procoagulant markers, growth factor release and cell proliferation.
    Frelinger AL; Torres AS; Caiafa A; Morton CA; Berny-Lang MA; Gerrits AJ; Carmichael SL; Neculaes VB; Michelson AD
    Platelets; 2016; 27(2):128-35. PubMed ID: 26030682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.
    Rappolee DA; Mark D; Banda MJ; Werb Z
    Science; 1988 Aug; 241(4866):708-12. PubMed ID: 3041594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel therapeutic approaches in utilizing platelet lysate in regenerative medicine: Are we ready for clinical use?
    Zamani M; Yaghoubi Y; Movassaghpour A; Shakouri K; Mehdizadeh A; Pishgahi A; Yousefi M
    J Cell Physiol; 2019 Aug; 234(10):17172-17186. PubMed ID: 30912141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia.
    Zauli G; Visani G; Catani L; Vianelli N; Gugliotta L; Capitani S
    Br J Haematol; 1993 Jan; 83(1):14-20. PubMed ID: 8435322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ex vivo production of platelets from stem cells.
    Avanzi MP; Mitchell WB
    Br J Haematol; 2014 Apr; 165(2):237-47. PubMed ID: 24521452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structurally graduated collagen scaffolds applied to the ex vivo generation of platelets from human pluripotent stem cell-derived megakaryocytes: Enhancing production and purity.
    Shepherd JH; Howard D; Waller AK; Foster HR; Mueller A; Moreau T; Evans AL; Arumugam M; Bouët Chalon G; Vriend E; Davidenko N; Ghevaert C; Best SM; Cameron RE
    Biomaterials; 2018 Nov; 182():135-144. PubMed ID: 30118981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of megakaryocytes and platelets from human subcutaneous adipose tissues.
    Matsubara Y; Saito E; Suzuki H; Watanabe N; Murata M; Ikeda Y
    Biochem Biophys Res Commun; 2009 Jan; 378(4):716-20. PubMed ID: 19059379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue.
    Chieregato K; Castegnaro S; Madeo D; Astori G; Pegoraro M; Rodeghiero F
    Cytotherapy; 2011 Sep; 13(8):933-43. PubMed ID: 21623669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ovariectomy increases mitogens and platelet-induced proliferation of arterial smooth muscle.
    Bracamonte MP; Rud KS; Owen WG; Miller VM
    Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H853-60. PubMed ID: 12181111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miRNAs can increase the efficiency of ex vivo platelet generation.
    Emmrich S; Henke K; Hegermann J; Ochs M; Reinhardt D; Klusmann JH
    Ann Hematol; 2012 Nov; 91(11):1673-84. PubMed ID: 22763947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery.
    Burnouf T; Chou ML; Lundy DJ; Chuang EY; Tseng CL; Goubran H
    J Biomed Sci; 2023 Sep; 30(1):79. PubMed ID: 37704991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.
    Tozawa K; Ono-Uruga Y; Yazawa M; Mori T; Murata M; Okamoto S; Ikeda Y; Matsubara Y
    Blood; 2019 Feb; 133(7):633-643. PubMed ID: 30487128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat-derived platelet concentrates.
    Glovinski PV; Herly M; Mathiasen AB; Svalgaard JD; Borup R; Talman MM; Elberg JJ; Kølle ST; Drzewiecki KT; Fischer-Nielsen A
    Cytotherapy; 2017 Feb; 19(2):222-234. PubMed ID: 27887865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
    Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
    Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Slowed decay of mRNAs enhances platelet specific translation.
    Mills EW; Green R; Ingolia NT
    Blood; 2017 Apr; 129(17):e38-e48. PubMed ID: 28213379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms of bleeding disorderassociated GFI1B
    van Oorschot R; Hansen M; Koornneef JM; Marneth AE; Bergevoet SM; van Bergen MGJM; van Alphen FPJ; van der Zwaan C; Martens JHA; Vermeulen M; Jansen PWTC; Baltissen MPA; Gorkom BAPL; Janssen H; Jansen JH; von Lindern M; Meijer AB; van den Akker E; van der Reijden BA
    Haematologica; 2019 Jul; 104(7):1460-1472. PubMed ID: 30655368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.